Inspira Technologies OXY B.H.N. ltd (Nasdaq: IINN) (Nasdaq: IINNW) (the “Company” or “Inspira Technologies”), a pioneering respiratory support technology company, announced today that it has signed an exclusive OEM (Original Equipment Manufacturing) agreement with Terumo Cardiovascular, a division of Terumo Corporation, a global leader in medical devices. Terumo Corporation operates in more than 160 countries and regions around the world, serving patients in a variety of healthcare settings with more than 50,000 products and services.
Terumo Cardiovascular is an expert in oxygenation systems, heart-lung machines and monitoring systems. The agreement calls for the manufacture of a flow mechanism to be integrated into Inspira Technologies’ products for use during the oxygenation process in the extracorporeal blood circulation. This may also include integration with the INSPIRATM ART System, designed to introduce a new way of delivering acute respiratory care by increasing oxygen saturation levels in minutes with small volumes of blood. The INSPIRA ART System is designed to treat patients while they are awake and breathing spontaneously, reducing the need for invasive mechanical ventilation.
Joe Hayon, Co-Founder and President of Inspira Technologies, stated, “This is a very important agreement for the company and we believe it aligns with our strategy of developing collaborations with the largest medical device companies who are helping us on our journey to market.”
